These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29153636)

  • 1. Early intervention for lactate dehydrogenase elevation improves clinical outcomes in patients with the HeartMate II left ventricular assist device: Insights from the PREVENT study.
    Thenappan T; Stulak JM; Agarwal R; Maltais S; Shah P; Eckman P; Emani S; Katz JN; Gregoric I; Keebler ME; Uriel N; Adler E; Chuang J; Farrar DJ; Sundareswaran KS; John R
    J Heart Lung Transplant; 2018 Jan; 37(1):25-32. PubMed ID: 29153636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
    Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic prediction of left ventricular assist device pump thrombosis based on lactate dehydrogenase trends.
    Hurst TE; Xanthopoulos A; Ehrlinger J; Rajeswaran J; Pande A; Thuita L; Smedira NG; Moazami N; Blackstone EH; Starling RC
    ESC Heart Fail; 2019 Oct; 6(5):1005-1014. PubMed ID: 31318170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study.
    Maltais S; Kilic A; Nathan S; Keebler M; Emani S; Ransom J; Katz JN; Sheridan B; Brieke A; Egnaczyk G; Entwistle JW; Adamson R; Stulak J; Uriel N; O'Connell JB; Farrar DJ; Sundareswaran KS; Gregoric I;
    J Heart Lung Transplant; 2017 Jan; 36(1):1-12. PubMed ID: 27865732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected abrupt increase in left ventricular assist device thrombosis.
    Starling RC; Moazami N; Silvestry SC; Ewald G; Rogers JG; Milano CA; Rame JE; Acker MA; Blackstone EH; Ehrlinger J; Thuita L; Mountis MM; Soltesz EG; Lytle BW; Smedira NG
    N Engl J Med; 2014 Jan; 370(1):33-40. PubMed ID: 24283197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of LDH isoenzymes in hemolysis and continuous-flow left ventricular assist device-induced thrombosis.
    Gordon JS; Wood CT; Luc JGY; Watson RA; Maynes EJ; Choi JH; Morris RJ; Massey HT; Throckmorton AL; Tchantchaleishvili V
    Artif Organs; 2020 Mar; 44(3):231-238. PubMed ID: 31494952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events.
    Salerno CT; Sundareswaran KS; Schleeter TP; Moanie SL; Farrar DJ; Walsh MN
    J Heart Lung Transplant; 2014 Aug; 33(8):809-15. PubMed ID: 24735680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon.
    Uriel N; Han J; Morrison KA; Nahumi N; Yuzefpolskaya M; Garan AR; Duong J; Colombo PC; Takayama H; Thomas S; Naka Y; Jorde UP
    J Heart Lung Transplant; 2014 Jan; 33(1):51-9. PubMed ID: 24290832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are elevated serum haemolysis markers a harbinger of adverse events in HeartMate II patients?
    Zayat R; Shoaib M; Khattab MA; Ahmad U; Goetzenich A; Stoppe C; Foldenauer AC; Moza A; Schnoering H; Autschbach R; Tewarie L
    Interact Cardiovasc Thorac Surg; 2018 Jul; 27(1):5-12. PubMed ID: 29444250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pump Position Impacts HeartMate II Left Ventricular Assist Device Thrombosis.
    Kilic A; Ransom J; Maltais S; Sun B; Entwistle JW; Bailey S; John R; Klodell CT; Gregoric I; Sheridan B; Chuang J; Farrar DJ; Sundareswaran K; Adamson R
    ASAIO J; 2019; 65(3):227-232. PubMed ID: 29952801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices.
    Gavalas MV; Breskin A; Yuzefpolskaya M; Eisenberger A; Castagna F; Demmer RT; Flannery M; Garan AR; Takeda K; Takayama H; Naka Y; Topkara VK; Colombo PC
    J Heart Lung Transplant; 2017 Jan; 36(1):59-63. PubMed ID: 27773451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Detection of Pump Thrombosis in Patients With Left Ventricular Assist Device.
    Grabska J; Schlöglhofer T; Gross C; Maw M; Dimitrov K; Wiedemann D; Zimpfer D; Schima H; Moscato F
    ASAIO J; 2020 Apr; 66(4):348-354. PubMed ID: 31294721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death.
    Levin AP; Saeed O; Willey JZ; Levin CJ; Fried JA; Patel SR; Sims DB; Nguyen JD; Shin JJ; Topkara VK; Colombo PC; Goldstein DJ; Naka Y; Takayama H; Uriel N; Jorde UP
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolysis in left ventricular assist device: a retrospective analysis of outcomes.
    Ravichandran AK; Parker J; Novak E; Joseph SM; Schilling JD; Ewald GA; Silvestry S
    J Heart Lung Transplant; 2014 Jan; 33(1):44-50. PubMed ID: 24418733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS Registry.
    Kirklin JK; Naftel DC; Pagani FD; Kormos RL; Myers S; Acker MA; Rogers J; Slaughter MS; Stevenson LW
    J Heart Lung Transplant; 2015 Dec; 34(12):1515-26. PubMed ID: 26681121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Courses of HeartMate II Left Ventricular Assist Device Thrombosis.
    Kittipibul V; Xanthopoulos A; Hurst TE; Fukamachi K; Blackstone EH; Soltesz E; Starling RC
    ASAIO J; 2020 Feb; 66(2):153-159. PubMed ID: 30688690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Related to Pump Thrombosis With the Heartmate II Left Ventricular Assist Device.
    Klodell CT; Massey HT; Adamson RM; Dean DA; Horstmanshof DA; Ransom JM; Salerno CT; Cowger JA; Aranda JM; Chen L; Long JW; Dembitsky W
    J Card Surg; 2015 Oct; 30(10):775-80. PubMed ID: 26283153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and Risk Factor Analysis for Gastrointestinal Bleeding and Pump Thrombosis in Left Ventricular Assist Device Recipients.
    Lopilato AC; Doligalski CT; Caldeira C
    Artif Organs; 2015 Nov; 39(11):939-44. PubMed ID: 25912789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
    Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
    J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical technique influences HeartMate II left ventricular assist device thrombosis.
    Taghavi S; Ward C; Jayarajan SN; Gaughan J; Wilson LM; Mangi AA
    Ann Thorac Surg; 2013 Oct; 96(4):1259-1265. PubMed ID: 23968757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.